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Chondrocytes Utilize a Cholesterol-Dependent Lipid Translocator to Externalize
Phosphatidylserine
Abstract
During endochondral ossification, growth plate chondrocytes release plasma membrane (PM) derived
matrix vesicles (MV), which are the site of initial hydroxyapatite crystal formation. MV constituents which
facilitate the mineralization process include the integral membrane ectoenzymes alkaline phosphatase
(ALPase) and nucleotide pyrophosphatase phosphodiesterase (NPP1/PC-1), along with a
phosphatidylserine-(PS-) rich membrane surface that binds annexins and calcium, resulting in enhanced
calcium entry into MV. In this study, we determined that chick growth plate MV were highly enriched in
membrane raft microdomains containing high levels of cholesterol, glycophosphatidylinositol- (GPI-)
anchored ALPase, and phosphatidylserine (PS) localized to the external leaflet of the bilayer. To
determine how such membrane microdomains arise during chondrocyte maturation, we explored the role
of PM cholesterol-dependent lipid assemblies in regulating the activities of lipid translocators involved in
the externalization of PS. We first isolated and determined the composition of detergent-resistant
membranes (DRMs) from chondrocyte PM. DRMs isolated from chondrocyte PM were enhanced in
ganglioside 1 (GM1) and cholesterol as well as GPI-anchored ALPase. Furthermore, these membrane
domains were enriched in PS (localized to the external leaflet of the bilayer) and had significantly higher
ALPase activity than non-cholesterol- enriched domains. To understand the role of cholesterol-dependent
lipid assemblies in the externalization of PS, we measured the activities of two lipid transporters involved
in PS externalization, aminophospholipid translocase (APLT) and phospholipid scramblase (PLSCR1),
during maturation of a murine chondrocytic cell line, N1511. In this report, we provide the first evidence
that maturing chondrocytes express PLSCR1 and have scramblase activity. We propose that redistribution
of PS is dependent on an increase in phospholipid scramblase activity and a decrease in APLT activity.
Lastly, we show that translocator activity is most likely to be modulated by membrane cholesterol levels
through a membrane raft microdomain. © 2006 American Chemical Society.
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ABSTRACT: During endochondral ossification, growth plate chondrocytes release plasma membrane (PM)
derived matrix vesicles (MV), which are the site of initial hydroxyapatite crystal formation. MV constituents
which facilitate the mineralization process include the integral membrane ectoenzymes alkaline phosphatase
(ALPase) and nucleotide pyrophosphatase phosphodiesterase (NPP1/PC-1), along with a phosphatidylserine(PS-) rich membrane surface that binds annexins and calcium, resulting in enhanced calcium entry into
MV. In this study, we determined that chick growth plate MV were highly enriched in membrane raft
microdomains containing high levels of cholesterol, glycophosphatidylinositol- (GPI-) anchored ALPase,
and phosphatidylserine (PS) localized to the external leaflet of the bilayer. To determine how such membrane
microdomains arise during chondrocyte maturation, we explored the role of PM cholesterol-dependent
lipid assemblies in regulating the activities of lipid translocators involved in the externalization of PS.
We first isolated and determined the composition of detergent-resistant membranes (DRMs) from
chondrocyte PM. DRMs isolated from chondrocyte PM were enhanced in ganglioside 1 (GM1) and
cholesterol as well as GPI-anchored ALPase. Furthermore, these membrane domains were enriched in PS
(localized to the external leaflet of the bilayer) and had significantly higher ALPase activity than noncholesterol-enriched domains. To understand the role of cholesterol-dependent lipid assemblies in the
externalization of PS, we measured the activities of two lipid transporters involved in PS externalization,
aminophospholipid translocase (APLT) and phospholipid scramblase (PLSCR1), during maturation of a
murine chondrocytic cell line, N1511. In this report, we provide the first evidence that maturing
chondrocytes express PLSCR1 and have scramblase activity. We propose that redistribution of PS is
dependent on an increase in phospholipid scramblase activity and a decrease in APLT activity. Lastly, we
show that translocator activity is most likely to be modulated by membrane cholesterol levels through a
membrane raft microdomain.

Vertebrate skeletal growth occurs largely through a highly
regulated process known as endochondral ossification. During this process mesenchymal cells condense and differentiate
into chondrocytes to form a cartilage template. Chondrocytes
proliferate and then undergo a complex maturation process
associated with an increase in cell size (hypertrophy). This
hypertrophic stage is characterized by upregulation of the
expression of genes encoding ALPase,1 type X collagen, and
matrix metalloproteinase-13, followed by mineralization of
the extracellular matrix. The zones of proliferating, prehy†
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pertrophic and hypertrophic chondrocytes form the growth
plate cartilage that controls the longitudinal growth of
endochondral bone (1).
In calcifying cartilage, ALPase containing MV bud from
the cell membrane and are released into the matrix, where
they are believed to form the initial site of mineral development (2-4). MV budding from chondrocyte membranes is
believed to occur at localized areas with a distinctive
membrane composition. This conclusion is supported by
comparative lipid and protein studies of the MV and the PM
of the epiphyseal chondrocytes; MV contain higher concentrations of acidic phospholipids [phosphatidylserine (PS) and
phosphatidylinositol (PI)] than the chondrocyte PM, and MV
contain fewer proteins than PM (5). Previous studies in our
laboratories have shown that MV function depends on
membrane-anchored ALPase and the ability of the PS-rich
membrane surface to recruit annexins and to be permissive
for annexin-mediated Ca2+ entry (5, 6). The latter activity
is critically dependent on the presence of high levels of
membrane PS. We have also shown that hypertrophic
chondrocyte cultures can form vesicles which are very similar
to MV formed in vivo (7). These investigations indicated
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subtle structural differences in the composition of the two
membranes, suggesting that MV originate from specific sites
on the chondrocyte plasma membrane through a rearrangement of membrane components.
Two key features of MV, therefore, are the high levels of
ALPase activity and the externalization of PS. Both of these
membrane-associated processes may arise from PM assemblies, which form during chondrocyte development. It
is well documented that many plasma membranes consist
of microscopically and biochemically distinguishable lipid
microdomains, which form liquid-ordered phases in the lipid
bilayer and are dispersed in the bulk of the liquid-disordered
phase of the plasma membrane (8-14). Membrane bilayer
organization into these microdomains, known colloquially
as membrane rafts or lipid assemblies, provides the requisite
temporal and spatial organization of protein and lipid
components necessary for normal cellular function (15-18).
A unique property of these membrane rafts is their resistance
to solubilization by mild detergents such as Triton X-100
(at low temperature), NP-40, and Brij-98; this insolubility
is due, in part, to long saturated acyl chains of sphingomyelin
that impart a high degree of order and also by stabilization
of intercalating cholesterol molecules (8, 19).
In addition to their unique lipid profile, membrane rafts
also contain a number of proteins involved in signal
transduction, thereby providing a signaling platform that
enhances signal efficiency and specificity. The organization
of these assemblies restricts access so that only a limited
class of membrane proteins resides in rafts; these include
proteins attached to the membrane by a lipid anchor, such
as glycosylphosphatidylinoisitol- (GPI-) anchored proteins,
acylated cytosolic proteins, and certain transmembrane
proteins (15, 16, 20-22). Membrane rafts are involved in
cellular processes as diverse as fertilization, viral infection,
maintenance of cell polarity, chemotaxis, apoptosis, and
development (15, 16, 22-28). Processes which involve
changes in the shape of the cell, including domain-induced
budding and possibly MV formation, are associated with
membrane microdomains (29-34). On the basis of our
studies, we propose that a reorganization of cholesteroldependent lipid assemblies; i.e., lipid rafts, is a prerequisite
for chondrocyte hypertrophy, an event considered critical for
cartilage mineralization.
The phospholipid composition of the chondrocyte membrane is also crucial for function. PS is linked to the
recruitment of annexin V which functions as a Ca2+ channel
(6, 35). Annexin binding requires a charged PS-rich cytoplasmic membrane leaflet and the maintenance of normal
lipid asymmetry. PS asymmetry is maintained by at least
two lipid translocators, the calcium-independent, aminophospholipid translocase (APLT), involved in actively transporting PS from the outer to the inner monolayer, and the
calcium-dependent phospholipid scramblase (36-38). Apoptotic cells, including terminally differentiated chondrocytes,
exhibit an externalization of PS which is accompanied by
both a loss of APLT activity and an increase in phospholipid
scramblase activity (36, 39-42). In the experiments described below we show that (i) chondrocytes express
phospholipid scramblase 1 (PLSCR1), (ii) PLSCR1 expression appears to be upregulated in BMP/Ins-treated cells, (iii)
scramblase activity increases and amino phospholipid translocase activity decreases in early chondrocyte hypertrophy
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resulting in the externalization of PS, and (iv) these lipid
translocator activities are dependent on membrane cholesterol
levels.
MATERIALS AND METHODS
Release of Chicken Epiphyseal Growth Plate Chondrocytes
and MV. Growth plate cartilage harvested from 8-10-weekold chicken tibia was minced and initially incubated (16 h
at 4 °C) in digestion medium consisting of Hank’s balanced
salts solution (HBSS; Sigma, St. Louis, MO) containing
bacterial collagenase (0.5%; Worthington) and hyaluronidase
(7.5 units/mL; Sigma) and incubated in fresh digestion
medium for 3 h at 37 °C. The minced digested cartilage was
washed with cold HBSS (twice) to remove residual enzyme
activity. Chondrocytes and MV were released by repeated
trituration (30-40 cycles) through a 10 mL glass pipet. The
resultant slurry was passed through a 40 mesh stainless steel
sieve, the retentate resuspended in HBSS, and trituration
repeated until 120-130 mL of filtrate was accumulated. The
filtrate was centrifuged for 5 min at 10000g. The supernate
(S1) was used to isolate MV, while the pellet (P1) was used
to prepare chondrocyte plasma membrane.
Isolation of Matrix Vesicles. Supernate S1 was clarified
by centrifugation at 15000g for 15 min, and MV were
collected by centrifugation at 140000g for 240 min. MV
pellets were resuspended in TES-salt buffer (10 mM TESHCl, pH 7.4, and 150 mM NaCl; TSB) and purified by
isopycnic density gradient centrifugation on sucrose density
gradients (0-65% sucrose, in TSB) centrifuged at 197000g
for 20 h.
Isolation of Chondrocyte Plasma Membranes. Red blood
cells (RBCs) were manually removed from the pellet fraction
(P1), and the residual chondrocyte pellet was resuspended
in HBSS and centrifuged at 10000g for 5 min. Any residual
RBCs were lysed by resuspension of the chondrocyte pellet
in 5 mL of distilled water. After 2 min tonicity was restored
with the addition of an excess of HBSS (4-fold), and
chondrocytes resedimented. The chondrocyte pellet was
resuspended in 50-60 mL of HBSS, and debris was removed
by passage of the suspension sequentially through cheesecloth. The purified chondrocytes were subsequently sedimented and resuspended in TSB. Cells were lysed by rapid
passage through an 18 gauge needle to maximize cell
breakage and minimize organelle damage (43). Plasma
membranes (PM) were isolated by isopycnic gradient
centrifugation as described above. The purified MV and
chondrocyte membrane preparations were analyzed for the
RBC plasma membrane marker glycophorin-C (44). Our
analysis showed no detectable glycophorin from contaminating RBC membrane as determined by Western blot analysis
(data not shown). This analysis was expected to detect as
little as 1 pg of glycophorin/20 µg of membrane protein. In
addition, the cell suspensions, corresponding to 5 × 105
chondrocytes/mL, contained no detectable heme based
on spectrophometric analysis at 420 nm (data not shown).
This analysis allows us to detect as little as 10 pg of heme/
mL of cell suspension, which corresponds to 0.333 RBC/
mL.
Isolation of Triton X-100 Resistant Membrane Rafts. Triton
X-100 resistant membrane rafts were prepared from chick
chondrocyte PM and chick matrix vesicles essentially as
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described previously for photoreceptors (45). Briefly, purified
chondrocyte PM or MV were washed, and the pellet was
resuspended in 1 mL of MOPS buffer. Triton X-100 (2%
w/v) was added to the cell suspension to yield a final
concentration of 1% Triton X-100; this corresponds to 0.77
mL of 2% Triton X-100. To distinguish between Triton
X-100 resistant membranes and nonraft partial detergent
dependent solubilization, control cells were homogenized in
2% octyl glucopyranoside (OG) in parallel with Triton X-100
treated samples. Both Triton X-100 and OG treated samples
were homogenized with three passes of a glass pestle through
a glass Tenboeck tissue grinder. The detergent homogenate
was mixed with 1.24 mL of 2.4 M sucrose to yield a final
sucrose concentration of 0.9 M, transferred to a SW 41
centrifuge tube, overlayed with 1.0 mL of 0.8, 0.70, 0.65,
0.60, 0.55, and 0.50 M sucrose, and centrifuged at 40000
rpm for 20 h at 4 °C.
Analysis of Lipid Composition. Cholesterol (46) and total
phosphate (47) were determined by standard procedures.
Lipids were extracted from the low buoyant density fraction
by a modification of the procedure of Bligh and Dyer (48);
prior to the extraction of lipids from the detergent-solublized
fractions, these samples were dialyzed for 48 h against two
changes of 10 mM Hepes and 0.5 M NaCl, pH 7.4, to
decrease the detergent concentration (49). In both PM and
MV preparations, 90 ( 3.6% of the total phospholipid was
extracted, indicating that the presence of residue detergent
(Triton X-100 or OG) in the solublized fractions did not
interfere with the extraction. Chloroform extracts were
evaporated under nitrogen and diluted into chloroform
immediately prior to lipid analysis by gradient elution using
normal phase HPLC/ELSD (Avanti-Polar Lipids, Alabaster,
AL). Standards (1 mg/mL) included triolein, cholesterol,
ceramide, oleic acid, phosphatidylglycerol (PG), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidic acid (PA), and soy phosphatidylinositol (PI). Standards and samples were injected on a
normal phase HPLC column and analyzed by an evaporative
light scattering detector (ELSD). A five-level calibration
curve was used to calculate the amount of lipid species in
each sample. In addition, chloroform extracts were analyzed
by sequential thin-layer chromatography. The lipids were
resolved on silica gel H plates developed in chloroform/
methanol/acetic acid/water (25:15:4:2). The plates were
developed in the same solvent system three times (50). Spots
were identified by comparison to the migration patterns of
known standards following staining with Dragendorf, ninhydrin, and sulfuric acid charring. The spots were scraped,
and total phosphate was determined (47).
Ganglioside 1 (GM1) in the detergent-resistant and soluble
fractions was detected by spotting 1 µL of sample directly
onto nitrocellulose membranes. Membranes were blocked in
BLOTTO, incubated at 21 °C with the β-subunit of cholera
toxin (CtB; 85 ng/mL; Sigma) for 12 h, washed and exposed
to anti-CTB conjugated to horseradish peroxidase, and
analyzed by digital densitometry (Kodak Image Systems).
Samples were adjusted for phosphate content.
N1511 Cell Culture and Induction with BMP-2/Insulin in
Serum-Free Media. N1511 cells (51) (obtained from Dr. M.
Iwamoto and Dr. V. Srinivas, Thomas Jefferson University,
Philadelphia, PA) were plated at a high density (1.7 × 106
cells per well) in six-well plates and cultured in R-minimum
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essential media (R-MEM) supplemented with 10% FBS and
1% penicillin/streptomycin at 37 °C in 5% CO2 (all reagents
were from Sigma-Aldrich Co., St. Louis, MO). After 24 h
the culture medium was changed to 0.3% FCS media, and
the cells were induced with 50 ng/mL recombinant human
BMP-2 (R&D Systems, Minneapolis, MN) and 1 × 10-6 M
bovine insulin (Life Technologies, Inc., Grand Island, NY).
L-Ascorbic acid phosphate magnesium salt (50 µg/mL; Wako
Pure Chemical Industries, Ltd.) was also added directly into
each well. Untreated cells in complete media constituted a
control. The medium was changed every other day. On the
third, fifth, seventh, and tenth day of treatment, total RNA
was harvested from one set of cells, and the other set was
stained for alkaline phosphatase.
During differentiation, prechondrocytes cease producing
type I collagen and express cartilage-specific extracellular
matrix genes encoding aggrecan and cartilage-specific collagens such as type II. Upon hypertrophy, they express type
X collagen and upregulate ALPase. Within 72 h of BMP/
Ins treatment, aggrecan mRNA had appeared, and Col II had
decreased (data not shown). Extracellular MV were observed
within 20 days (data not shown).
Laser Confocal Microscopy. N1511 cells were plated at a
high density of 1.7 × 106 cells per Delta TPG 0.17 mm
(black) dish (Fisher Scientific) and cultured in R-minimum
essential media supplemented with 10% fetal calf serum and
1% penicillin/streptomycin at 37 °C in 5% CO2 (all reagents
were from Sigma-Aldrich Co.). After 24 h the cells were
induced with 50 ng/mL recombinant human BMP-2 (R&D
Systems), 1 × 10-6 M bovine insulin (Life Technologies,
Inc.), and 50 µg/mL L-ascorbic acid phosphate (Wako) in
media containing 0.3% FCS. The media were changed every
other day. On the given day of treatment the cells were
stained with 7 µg/mL cholera toxin conjugated to AlexaFluor
594 (Molecular Probes) (shown in red) to label GM1. GM1
was cross-linked with 40 µg/mL (1:25 dilution) anti-cholera
toxin (Calbiochem) before fixation of cells with 2% paraformaldehyde. The cells were co-stained with 5 µg/mL rabbit antiPLSCR Ab-1 (Oncogene) and subsequently incubated with
goat anti-rabbit IgG AlexaFluor 488 secondary antibody at
a concentration of 8 µg/mL (Molecular Probes) (shown in
green). The fluorescent dye 4′,6′-diamidino-2-phenylindole
(DAPI; Sigma) was used to visualize nuclei (shown in blue).
Images of cells were taken on a Bio-Rad Radiance 2100
confocal microscope (Bio-Rad, Hercules, CA) using a 60×
objective. DAPI, AlexaFluor 488, and AlexaFluor 594
fluorescence was excited by blue diode, argon (488 nm), and
red diode lasers, respectively. Fluorescence emission was
captured using the following filters: 376 ( 24 nm (DAPI),
515 ( 30 nm (AlexaFluor 488), and above 600 nm
(AlexaFluor 594). All images were captured with the same
laser settings. Analysis of fluorescent probe colocalization
was performed using image analysis software (Metamorph;
Universal Imaging Corp., Downingtown, PA). Regions of
interest were defined to include cells that did not overlap.
The region was segmented to select pixels above a constant
threshold value (>60% above background) which represent
true fluorescence. Since both spatial location and intensity
of pixels contribute to colocalization, the values represent
the integrated intensity; pixels in both AlexaFluor 488 and
AlexaFluor 594 images had similar brightness values and
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spatial location. Colocalization analysis was performed on
all cells present in Figure 5.
RNA Isolation and Analysis. The cell layer was washed
with PBS, and total RNA was isolated using TRI reagent
(Molecular Research Center, Inc., Cincinnati, OH). RNA
yield was determined by absorbance at 260 nm and integrity
confirmed by gel electrophoresis. Total RNA (5 µg) was
converted into cDNA using the SuperScript first-strand
synthesis system for RT-PCR (Invitrogen, Carlsbad, CA).
The cDNA samples were amplified in a Smart Cycler
(Cepheid, Inc., Sunnyvale, CA) with LightCycler Fast-Start
DNA Master SYBR Green I reagent (Roche Molecular
Biochemicals, Mannheim, Germany) using specific primers.
Gene expression was normalized using GAPDH primers.
Specific primers for collagen X and PLSCR1 were designed
as follows: Col X, (F) cgtgtctgcttttactgtca, (R) acctggtcattttctgtgag; PLSCR1, (F) tagctgctgttccgacattg, (R) tgctcctcgtttccagttct. The results from real-time RT-PCR were
obtained as crossing points, indicating the number of cycles
required for fluorescence of the PCR product to increase
above threshold value. These crossing points were converted
to arbitrary units of mRNA assuming a concentrationdependent straight line for a semilog plot, with a value of
3.5 for the fold change in mRNA/cycle (slope), and the
crossing point cycle number with no template as an estimate
of the y-intercept (52, 53). A final melt curve from 60 to 95
°C was performed to confirm the specificity of the PCR,
and the identities of PCR products were checked by gel
electrophoresis.
Alkaline Phosphatase ActiVity and Staining. Alkaline
phosphatase activity was assayed in a reaction mixture
containing p-nitrophenyl phosphate (5 mM) in Tris-HCl
buffer (1.5 M, pH 9.0) supplemented with ZnCl2 (1.0 mM)
and MgCl2 (1.0 mM). Enzyme activity was monitored by
following the production of p-nitrophenol at 410 nm in a
recording spectrophotometer. Rates were expressed as micromoles of p-nitrophenol per minute per milligram of
protein (in membrane raft preparations) and nanomoles of
p-nitrophenol per minute per 1 × 106 cells in N1511
experiments. In both cases, a value of 16.0 was used for the
millimolar extinction coefficient. Protein assays were performed using the Micro BCA protein assay reagent kit
(Pierce, Rockford, IL). For alkaline phosphatase staining, cell
monolayers were washed twice with TBS, fixed in 2%
paraformaldehyde in methanol for 1 min at 4 °C, and stained
with naphthol AS-BI (Sigma).
Phospholipid Uptake. Aminophospholipid translocase
(APLT) and phospholipid scramblase activities were measured
using a well-characterized fluorescent lipid-uptake assay as
described (36, 54, 55). APLT activity was determined by
the uptake of 1-oleoyl-2-[6-[(7-nitro-2,1,3-benzoxadiazol-4yl)amino]caproyl]-sn-glycero-3-phosphoserine (NBD-PS),
and scramblase activity was determined by the uptake of
1-palmitoyl-2-[6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]caproyl]-sn-3-glycerophosphocholine (NBD-PC). Briefly,
treated cells (1 × 106) were washed and resuspended in 100
µL of Hepes-buffered saline (HBS) (137 mM NaCl, 2.7 mM
KCl, 2 mM MgCl2, 5 mM glucose, 10 mM Hepes, pH 7.4).
Cells were incubated with 1 µL of NBD-lipid (50 µg/mL)
at 37 °C for 30 min. Following incubation, cells were washed
with 50 µL of 1% BSA to remove unincorporated probe lipid.
Cells were subsequently labeled with 1 µL of propidium
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iodide (250 µg/mL) for 10 min. Samples were transferred
to ice, diluted with 900 µL of HBS, and analyzed within 1
h on a Becton-Dickinson FacstarPLUS flow cytometer (BD
Biosciences, San Jose, CA). The mean fluorescence values
of phospholipid uptake were determined by gating on viable
(propidium iodide negative) cells. NBD and propidium iodide
fluorescence was excited using an argon laser at 488 nm
and fluorescence measured with a 530/30 nm and 630/22
nm band-pass filter, respectively. Fluorescence was detected
using log amplification; a minimum of 10000 events were
collected on each sample.
PS Externalization. Acyl-chain-labeled NBD-PS was
incorporated into N1511 cells (1 × 106 cells/mL) as described
above. All fluorescence measurements were performed on a
Perkin-Elmer LS55B spectrofluorometer. Prior to the start
of each experiment, CaCl2 was added to the cell suspensions
to a final concentration of 1 µM, and cells were transferred
to cuvettes placed in a water- jacketed turret at 37 °C.
Fluorescence of NBD-lipids was measured with excitation
at 470 nm and emission at 525 nm. NBD-PS distribution
was measured using a dithionite quenching assay as described
(56). Briefly, the initial fluorescence (designated F0) of the
sample was recorded; 30 µL of 1 M dithionite was then
added, and the fluorescence decrease was followed over time
(usually 120 s) as the NBD probe in the outer monolayer
was quenched. The addition of twice the amount of dithionite
resulted in no additional quenching within the short 2 min
incubation time. The fluorescence value Fr was recorded after
the reaction was complete and the fluorescence had remained
unchanged for 10 s. The addition of Triton X-100 caused a
further decrease in fluorescence, such that essentially all of
the remaining fluorescence was destroyed. When Triton
X-100 was added prior to dithionite treatment, the addition
of dithionite resulted in the quenching of 100% of the NBD
fluorescence. Fluorescence values were corrected for the
background fluorescence of unlabeled cells (designated Fapp),
which did not change over the course of the experiments.
The amount of NBD-lipid accessible to dithionite was
calculated from the decrease in cell-associated fluorescence
after quenching with dithionite using the formula:

% accessible ) {1 - [(Fr - Fapp)/(F0 - Fapp)]} × 100
Statistical Analyses. All data were analyzed using Sigma
Stat software, Version 3.1, as described in the figure legends.
The real-time RT-PCR samples were compared using a
Tukey test in which P values below 0.050 were considered
to show a statistically significant difference based on twoway ANOVA analysis. ANOVA on ranks was performed
in order to test differences over time in the scramblase
activity measured using flow cytometry. For the remaining
cases one-way ANOVA was used for testing the differences
in the lipid translocator activity.
RESULTS
Isolation of Triton X-100 Resistant Chondrocyte and
Matrix Vesicle Fractions. Cartilage mineralization requires
the formation of membrane buds termed matrix vesicles,
which are enriched in ALPase, annexins II, V, and VII, and
that associate with collagen types II and X. A number of
these proteins require association with the membrane surface: ALPase through a GPI-linked anchor and annexin with
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Table 1: Characteristics of Chondrocyte and Matrix Vesicle
Detergent Resistant Membranes (DRMs)a
% total
phospholipid

sample
chondrocytes
chondrocyte rafts
MV
MV rafts

6.9 ( 2.1
32 ( 4.6

Chol/Phos

% total
GM1

0.37-0.48
0.92-1.3
0.48-0.57
0.84-1.2

19.5 ( 2.4
80 ( 4.9
3.5 ( 1.2
95 ( 7.8

a

Chol/Phos refers to the cholesterol to phospholipid mole ratio of
the various membrane fractions. Lipid phosphate and GM1 analyses
represent the mean ( standard deviation of three independent preparations, each assayed in duplicate.
Table 2: Alkaline Phosphatase Activity of the Chondrocyte and
MV Membrane Preparationa
sample

ALPase specific activity

purified chondrocyte membranes
chondrocyte rafts
purified MV

0.58 ( 0.19
3.0 ( 1.2
6.3 ( 1.5

a Alkaline phosphatase activity is expressed as millimoles of
p-nitrophenyl phosphate per minute per milligram of protein and
represents the mean ( standard deviation of four independent preparations, each assayed in duplicate.

FIGURE 1: Lipid profiles of chondrocyte and MV detergent resistant
membranes. Cholesterol and sphingomyelin content of (A) chondrocyte membranes and (B) MV was determined as described in
Materials and Methods in both detergent-soluble (solid black bars)
and DRM fractions (white bars). Phospholipid profile of (C)
chondrocyte membranes and (D) MV was determined as described
in Materials and Methods in both detergent-soluble (solid black
bars) and DRM fractions (white bars). Briefly, lipids were extracted
from detergent-soluble and -insoluble fractions, the extract was dried
down and resuspended, and phospholipids were separated using
HPLC-ELSD or sequential 1D thin-layer chromatography (TLC)
on silica gel G. All lipid analyses are an average of four individual
analyses from three independent preparations.

PS-rich microdomains. Chondrocyte and MV-specific membrane microdomains were isolated by exploiting the relative
insolubility of cholesterol-enriched membrane microdomains
in detergent. Chondrocyte detergent-resistant membranes
(DRMs) were isolated as a low buoyant density opaque band
observed at a refractive index of 1.362, equal to 19% sucrose.
Triton X-100 treated matrix vesicles showed a similar
banding pattern with a low buoyant density band isolated at
a RI ) 1.3565, equal to 15.5% sucrose. The detergent-soluble
fractions were isolated at 35% sucrose. To account for
nonspecific partial detergent solubilization of the membrane,
samples were also lysed in 1% octyl glucopyranoside as a
control.
The lipid composition of DRMs was analyzed for the
membrane raft markers cholesterol, sphingomyelin, and
GM1. As shown in Figure 1A,B, cholesterol accounts for
approximately 50% of the total lipid in both chondrocyte
(Figure 1A) and MV (Figure 1B) DRMs. Although sphingomyelin accounted for less than 10% of the total lipid in
both chondrocyte membrane preparations and MV, it was
enhanced in both chondrocyte and MV DRMs (Figure 1A,B).
In addition, both chondrocyte and MV DRMs were enriched
in GM1 (Table 1). To determine what proportion of the
membrane phospholipid was resistant to detergent extraction,

phosphate levels in DRMs were compared to those in the
detergent-soluble fractions. Interestingly, chondrocyte DRMs
comprised 6.9% of the total membrane phospholipid, while
MV rafts comprised over 32% of the total phospholipid
(Table 1). Nonfractionated chondrocyte membranes had
ALPase levels per milligram of protein that were one-fifth
that of membrane rafts, and the ALPase specific activity in
purified MV was only twice that in raft preparations (Table
2).
Although membrane assemblies are enriched in a number
of lipids, the phospholipid profile of membrane microdomains varies considerably; for example, platelets contain
PS-enriched membrane rafts (57, 58). Since chondrocyte
mineralization requires PS, we investigated the phospholipid
profile of MV and chondrocyte DRMs (Figure 1C,D).
Phosphatidylcholine content varied little between the detergentsoluble and detergent-insoluble membrane fractions. As
expected, little phosphatidylethanolamine (a nonraft phospholipid) was detected in either chondrocyte or MV raft
fractions. The most striking change in phospholipid content
was observed with PS. In chondrocyte membrane preparations, detergent-soluble PS makes up 21% of the total lipid
while in chondrocyte DRMs this lipid accounts for over 44%
of the phospholipid (Figure 1C); in matrix vesicles (Figure
1D), PS accounts for less than 20% of the total detergentsoluble lipid and over 30% of the MV DRMs. Phosphatidylinositol, a raft-associated signaling lipid, comprises almost
10% of the chondrocyte raft and 5% of MV rafts. Collectively, these results suggest that both chondrocyte and MV
DRMs have lipid profiles consistent with membrane rafts
(and will hereafter be referred to as such).
We further investigated the transbilayer distribution of PS
in the membrane using a fluorescence-quenching assay.
NBD-PS-labeled chondrocytes or MV were used to assess
outer monolayer PS detected as fluorescent probe quenched
with the addition of 1 M sodium dithionite (56, 59).
Chondrocyte DRMs isolated from the labeled membranes
showed slightly higher levels of externalized PS than the
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parent chondrocyte membrane (92 ( 1.0% vs 86 ( 0.4%).
Although present in much higher amounts, PS distribution
in the MV appeared to be more similar to cell membrane,
79 ( 0.5% vs 76 ( 0.9%, in rafts and parent membrane,
respectively. Collectively, these results suggest that the raftassociated PS in both membrane preparations is largely
external.
Lipid Translocator ActiVities Change during Chondrocyte
Maturation. Since both chondrocytes and MV rafts are
enriched in PS, we hypothesized that the maintenance of PS
asymmetry in chondrocytes may be a cholesterol-dependent
event. Thus we investigated the mechanism of PS translocation in maturing chondrocytes in a cartilage-derived clonal
chondrocytic cell line: N1511 cells (51). N1511 cells were
grown to confluence and treated with BMP-2 and insulin at
day 1. During differentiation, chondrocyte precursors cease
producing type I collagen and express cartilage-specific
extracellular matrix genes encoding aggregan and cartilagespecific collagens such as type II. Upon hypertrophy, they
express type X collagen. Consistent with studies by Kamiya
et al. (51), we observed that uninduced N1511 cells at
confluence showed little expression of Col X; by day 5, Col
X expression had increased and stayed elevated (Figure 2A).
The BMP-treated cells expressed higher levels of collagen
X mRNA than corresponding control cells (*, P < 0.001
from the Tukey test). On day 10 the collagen X expression
in the BMP-treated cells significantly increased as compared
to days 3 and 7 (#, P < 0.001 from the Tukey test) and
stayed elevated up through day 19 (data not shown). In
uninduced control cells the collagen X mRNA level was the
highest on day 7 as compared to day 3, 5, and 10 (**, P <
0.01 from the Tukey test).
Chondrocytes were analyzed for ALPase activity and cell
surface staining at days 3, 5, 7, and 10. As shown in Figure
2B, BMP/Ins-treated N1511 cells show surface ALPase
staining by day 3, with strong staining by days 7 and 10.
We observed some variability in ALPase staining within the
first 72 h postinduction, although in all experiments ALPase
staining increased to the maximum by day 10. Throughout
this same time period, ALP activity increased from 6.97 nmol
of p-nitrophenyl phosphate/min per 1 × 106 cells at day 3
to 127 nmol of p-nitrophenyl phosphate/min per 1 × 106
cells at day 10 (Figure 2C). Untreated control cultures
showed very few ALP-positive cells and no increase in
ALPase activity.
Using this model system, we assessed PLSCR1 expression,
lipid translocator activity, and PS distribution over the 10
day course of chondrocyte maturation, a time frame during
which the cells underwent hypertrophy. PS redistribution is
dependent on the relative activities of two lipid translocators,
the aminophospholipid translocase (APLT) and the phospholipid scramblase (36, 60). Using real-time RT-PCR to
analyze PLSCR1 mRNA levels, PLSCR1 expression in
N1511 cells did not change over the course of 10 days, with
or without BMP (Figure 3A). BMP/insulin-treated cells show
higher levels of PLSCR1 expression than control cells [*, P
< 0.05 compared with corresponding untreated (from the
Tukey test)]. PLSCR1 appeared to localize to the plasma
membrane in prehypertrophic (day 3) chondrocytes and a
portion redistributed to the nucleus as the cells underwent
late hypertrophy (Figure 3B). As shown in Figure 3C,
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FIGURE 2: Assessment of chondrocyte maturation. (A) Real-time
RT-PCR of collagen X expression. N1511 cells were plated at a
high density of 1.7 × 106 cells per well and induced with 50 ng/
mL recombinant human BMP-2 and 1 × 10-6 M insulin (solid
black bars). The cells in complete media constituted the control
(solid gray bars). At the given time points RNA was extracted from
cells and analyzed by real-time RT-PCR. The graph shows the mean
values ( SD, expressed in mRNA arbitrary units. BMP/Ins-treated
cells expressed higher levels of collagen X mRNA than corresponding controls as indicated by an * (P < 0.001 from the Tukey
test). On day 10 collagen X expression in BMP/Ins-treated cells
significantly increased as compared to days 3 and 7, as shown by
a # (P < 0.001 from the Tukey test). Collagen X expression in
control cells was the highest on day 7 as compared to days 3, 5,
and 10 (**, P < 0.001 from the Tukey test). (B) Surface ALPase
staining. Confluent N1511 cells were treated with BMP-2 and
insulin, at the days indicated, and cells were immunostained
for ALPase surface expression as described in Materials and
Methods. Representative data are shown from three different
experiments with similar results. (C) ALPase activity in cultured
chondrocytes. Confluent N1511 cells were treated with BMP-2 and
insulin, at the days indicated, and ALPase activity was measured
as described in Materials and Methods. The results are an average
of three individual inductions, with ALPase activity measured in
duplicate.

PLSCR1 protein levels in maturing chondrocytes remained
constant.
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FIGURE 3: Phospholipid PLSCR1 expression in N1511 cells during
chondrocyte differentiation. (A) Real-time RT-PCR of PLSCR1
expression in N1511 cells. N1511 cells were plated at a high
density. After 24 h (day 0) the cells were induced with 50 ng/mL
recombinant human BMP-2 (R&D Systems), 1 × 10-6 M bovine
insulin (Life Technologies, Inc.), and 50 µg/mL L-ascorbic acid
phosphate (Wako) in media containing 0.3% FCS. The cells in
complete media constituted the control. At the given time points
RNA was extracted from cells and analyzed by real-time RT-PCR.
The graph shows the mean values ( SD, expressed in mRNA
arbitrary units. BMP/insulin-treated cells show higher levels of
PLSCR1 expression than control cells as indicated by an *, with
a P < 0.05 compared with corresponding untreated cells. (B)
PLSCR1 localization in maturing chondrocytes. N1511 cells were
treated with anti-PLSCR1 Ab-1 as described in Materials and
Methods and assessed using laser confocal microscopy. (C)
Expression of PLSCR1 protein in N1511 cells. Confluent N1511
cells were treated with BMP-2 and insulin, at the days indicated
cells were isolated, and lysates were prepared in 35 mM OG. (A)
The cell lysate was subjected to reducing electrophoresis, immunoblotted, and probed with 1 µg of anti-PLSCR1 antibody/mL of
BLOTTO. (B) For actin protein loading controls, membrane was
stripped and reprobed with a 1:250 dilution of anti-actin antibody
(Santa Cruz Biotechnology).

Lipid translocator activity was measured by following
NBD fluorescent lipid uptake using flow cytometry (36, 41,
55). This well-characterized assay measures APLT activity
as uptake of NBD-PS and scramblase activity as uptake of
PC. Thus a decrease in APLT activity is manifest as little
NBD-PS uptake and enhanced scramblase activity measured
as an increase in NBD-PC uptake and the externalization of
PS. N1511 cells isolated at days 3, 5, 7, and 10 were
incubated with either acyl-chain-labeled NBD-PC or NBDPS to measure scramblase and APLT activity, respectively.
Representative cytometry histograms (Figure 4A) demonstrate APLT activity and scramblase activity. The activities
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of the translocators, determined as mean channel fluorescence
(MCF), are quantitatively compared in Figure 4B as percent
of control activity. Upon BMP/Ins treatment, the N1511 cells
showed a marked decrease in APLT activity and an initial
increase in scramblase activity that began to diminish by day
7 (Figure 4B) and further decreased by day 10. The
scramblase activity (solid bar) significantly increased at day
7 compared to day 3 (P < 0.05, from Dunn’s test). At days
7 and 10 a significant decrease in APLT activity (open bar)
was observed (P < 0.01, from the Student-Newman-Keuls
method). Omission of calcium from the buffer resulted in
no detectable outer leaflet PS and no change in scramblase
activity (data not shown), consistent with Ca2+-dependent
scramblase activity observed in platelets and other cell types
(61-65). To determine if the decreased APLT activity and
increased scramblase activity resulted in the externalization
of PS, the distribution of NBD-PS in the cells was measured
using dithionite quenching techniques. As shown in Figure
4C, a 50% increase in the amount of PS externalized to the
outer monolayer was observed by day 5, with no substantial
increase observed after day 7, at which time over 80% of
the PS had been externalized.
To determine if PLSCR1 localized to chondrocyte membrane rafts, N1511 cells isolated at various times, corresponding to stages of maturation, were first exposed to CtBAlexaFluor 594 to identify GM1, and patches representing
microdomains were induced by treatment with anti-CtB
antisera (Figure 5B,E,H,K). Cells were then exposed to antiPLSCR1 Ab for 2 h, washed, and stained with goat antirabbit IgG AlexaFluor 488 (Figure 5A,D,G,H). Analysis of
merged images indicates that PLSCR1 is membrane raft
associated in all samples; however, the relative levels of
association decrease as the cells proceed through the late
hypertrophic stage (Figure 5C,F,I,L). In the prehypertrophic
stage virtually all PLSCR1 (>86%) fluorescence is found
associated with the GM1 patches. In contrast, in hypertrophic
and late hypertrophic stages only 35% and 10% of the
PLSCR1 fluorescence was GM1 associated. Most intriguing
is the observation that, during this same time period, 26%
and 46% of the PLSCR1 fluorescence became associated
with the nucleus; the implications of this redistribution are
presently under investigation.
Since PLSCR1 appeared to be localized to membrane rafts,
we determined if scramblase activity was cholesterol dependent. Scramblase activity was measured in chondrocytes
treated with the cholesterol sequestrant, MβCD (66). Lipid
translocator activities of N1511 cells isolated at days 3, 5,
7, and 10 were determined using flow cytometry as shown
below in Figure 4A. These cells were immediately depleted
of membrane cholesterol with 2 mM MβCD for 15 min as
described (66). As shown in the cytometry histograms from
FACS analysis (Figure 6A), cholesterol depletion with
MβCD resulted in a net decrease in mean channel fluorescence in NBD-PC, indicating a decrease in scramblase
activity. Data for both scramblase activity and APLT activity
upon cholesterol depletion of BMP/insulin-treated chondrocytes are shown in Figure 6B. In the presence of MβCD,
scramblase activity decreased and was the lowest at day 5
(P < 0.001, from the Student-Newman-Keuls method).
Following MβCD addition, APLT activity at day 3 was
significantly elevated as compared to the other time points.
APLT activity was the lowest at day 7 (P < 0.05, from the
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FIGURE 4: Chondrocyte APLT and scramblase activities. N1511 cells isolated at the indicated times were labeled with either NBD-PS
(APLT activity) or NBD-PC (scramblase), stained with propidium iodide, and analyzed for transporter activity by flow cytometry as described
in Materials and Methods. (A) APLT and scramblase activity at day 5. Cytometry histograms are representative of data from three different
experiments with similar results; 15000 cells were analyzed for each sample. (B) APLT and scramblase activity in maturing chondrcoytes.
The percent change in mean channel fluorescence of NBD-PC, solid bars (scramblase activity), and NBD-PS, open bars (APLT activity),
is indicated as chondrocytes mature. This percent change was calculated as the fluorescence change between BMP/Ins-treated and control
cells as a function of BMP/Ins fluorescence for both APLT and scramblase activity. Mean fluorescence values were obtained by gating on
viable (PI negative) cells. Routinely, cell viability was between 90% and 95%. (C) Externalization of PS in maturing chondrocytes. N1511
cells isolated at the indicated time points and labeled with acyl-chain-labeled NBD-PS were treated with 1 M sodium dithionite, and the
change in fluorescence was recorded over 3 min. The solid line represents PS accessible to quenching in untreated control cells, and bars
represent PS accessible to quenching in BMP/Ins-treated cells. The results are an average of three independent measurements of PS
externalization. Error bars represent (SD, with n ) 3.

Student-Newman-Keuls method). It should also be noted
that the N1511 cells were not adversely affected by these
agents; viability profiles of cells treated with MβCD were
similar to control (untreated) cells (data not shown).
The association of cholesterol depletion with decreased
scramblase activity is not unexpected since PLSCR1 has been
shown to reside in cholesterol-enriched membrane rafts in
myelomas, neutrophils, platelets, and RBCs (61, 64). Interestingly, by day 10, the effect of cholesterol depletion (i.e.,
membrane raft disruption) on scramblase activity was almost
negligible, most likely due to the redistribution of PLSCR1
to the nucleus (Figure 3B, as seen previously (67). Collectively, these results suggest that PS externalization is
dependent on the relative activities of scramblase and ALPT,
most likely in a cholesterol-dependent manner.
DISCUSSION
In this study we provide the first evidence that membrane
phosphatidylserine redistribution in chondrocytes occurs at

an early stage in the maturation process, prior to late
hypertrophy. On the basis of analysis of lipid translocator
activities, we propose that the mechanism of externalization
involves an increase in scramblase activity and a decrease
in APLT activity. Cholesterol depletion studies suggest that
these activities and by inference PS externalization are
modulated by a decrease in membrane cholesterol.
It is well established that the process of chondrocyte
maturation that is associated with MV formation requires
an increase in the size of the chondrocyte and a change in
shape of the chondrocyte membrane (2, 68, 69). Such
changes in membrane architecture require both alterations
within the membrane lipid components (either through altered
synthesis or reorganization) and the regulated expression of
matrix vesicle specific proteins. A reorganization of membrane components is commonly mediated by a redistribution
of components within specialized membrane microdomains
known as rafts. These are cholesterol- and GM1-enriched
membrane domains that can be isolated as detergent-insoluble
complexes. Utilizing detergent isolation techniques, we
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FIGURE 5: Colocalization of PLSCR1 with GM1. N1511 cells were
treated with CTb conjugated to AlexaFluor 594 and patched with
anti-CTb antibody. The cells were then treated with anti-PLSCR1
Ab-1 as described in Materials and Methods and assessed using
laser confocal microscopy. Images of AlexaFluor 488 fluorescence
(panels A, D, G, and J) and AlexaFluor 594 fluorescence (panels
B, E, H, and K) are shown as well as merged images (panels C, F,
I, and L) showing both FITC (green) and AlexaFluor 594 (red)
fluorescence along with DAPI stained. In controls, panel M, N1511
cells were treated with CTb and a 50:50 mix of AlexaFluor 488
and AlexaFluor 594 secondary antibodies and co-stained with DAPI.
Results are representative of three experiments.

demonstrate that chondrocytes contain membrane raft domains comprising approximately 7% of the total membrane.
It is noteworthy that when this same microdomain was
isolated from MV, the lipid rafts comprised over 30% of
the total membrane. During phase 1 of mineralization
approximately this same percentage of membrane area (2535%) is involved in the formation of intramembranous
hydroxyapatite seed crystals (refs 2 and 3 and references cited
therein). Moreover, the ALPase specific activity in isolated
MV rafts was 10-fold higher than in rafts isolated from
chondrocyte membranes. Whether this increased ALPase
activity is due to higher levels of ALPase in these membranes
or to a membrane-mediated effect on ALPase activity
remains to be determined.
Rafts from chondrocyte membranes and matrix vesicles
were also found to be enriched in PS, a lipid not commonly
found at such high levels in these microdomains. The relative
amount of PS is, however, comparable to the levels of PS
observed in activated platelet rafts (57, 58, 70). In those
membranes, PS is required for the formation of the prothrombinase complex. PS asymmetry is maintained by the
relative activities of the lipid translocators, APLT and
scramblase (36, 40, 60). Activities of these translocators are
controlled by cytosolic calcium; when calcium levels exceed
1 mM, scramblase activity is enhanced and APLT activity
decreases. In our studies, chelation of calcium with EDTA
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FIGURE 6: Effect of MβCD on lipid translocator activity. N1511
cells isolated at the indicated times were labeled with either NBDPS or NBD-PC to access APLT or scramblase activity, respectively.
These cells were subsequently depleted of membrane cholesterol,
with a short (10 min) incubation with 10 mM MβCD, stained with
propidium iodide, and analyzed for transporter activity by flow
cytometry as described in Materials and Methods. (A) Cytometry
histograms are representative of data from three different experiments with similar results; 15000 cells were analyzed for each
sample. (B) The percent change in mean channel fluorescence
(MCF) values for scramblase activity (solid bars) and APLT activity
(open bars) upon cholesterol depletion with MβCD is indicated.
These mean fluorescence values were obtained by gating on viable
(propidium iodide negative) cells. The cells used in these experiments are the same as those used in the studies shown in Figure 4
(activity prior to cholesterol depletion). Parallel experiments verified
that MβCD did not adversely affect cell viability as determined by
propidium iodide exclusion. Routinely, cell viability was approximately 90%. Data were analyzed using a one-way ANOVA
analysis as described in Materials and Methods.

inhibited scramblase activity and blocked PS externalization
(data not shown). Further, PS is believed to play an important
role in MV function by regulating annexin V calcium channel
activity (6, 35). Thus, the high level of PS in rafts isolated
from maturing chondrocytes supports the contention that raft
formation in chondrocyte membranes is a precursor to and
an integral part of MV biogenesis. The phospholipid
composition of the MV rafts is somewhat unusual; although
high in PS and cholesterol it is relatively low in sphingomyelin and PI. Given that the MV itself is a portion of
specialized membrane which blebs from the parent chondrocyte membrane, its raft composition may be determined
by its specialized function in mineralization.
Our identification of PLSCR1 is the first report that
maturing chondrocytes express an isoform of this protein
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(71). PLSCR1 expression levels have been found to be
altered in some cell types but not others, with levels directly
correlated with stimulus-dependent movement of PS to the
cell surface, thus suggesting that the PLSCR1 has scramblase
activity (refs 36, 37, 41, and 42 and references cited therein).
Although in our chondrocyte model the level of PLSCR1
expression appears to be constant over the 7 day maturation
process, as is seen in neutrophils and some myeloma cells
(61, 64), scramblase activity is altered in response to a
decrease in chondrocyte membrane cholesterol. Lastly,
PLSCR1 appears to localize to the plasma membrane by day
3 and subsequently redistribute to the nucleus by day 7,
suggesting that it could be a multifunctional protein with
both signaling properties and lipid translocator activity. The
PLSCR1 gene is transciptionally activated by interferons and
various growth factors (72, 73). PLSCR1 phosphorylation
by cellular PKC γ promotes transbilayer redistribution of
lipids in apoptotic cells (74). PLSCR1 also interacts directly
with the β-secratase protein in amyloid plaque formation
(75). Lastly, PLSCR1 is phosphorylated by c-Abl, and
truncation of PLSCR1 is seen in a spontaneous murine
mutation of this gene, which is linked to a leukemogenic
transformation (76), although the precise role of PLSCR1
in the regulation of cell proliferation is unknown. Further
studies are clearly needed to assess the dual function of
PLSCR1 both in chondrocytes and in other systems.
Collectively, these results suggest that BMP/Ins induces
PLSCR1 expression and that, upon chondrocyte hypertrophy,
membrane rearrangement mediates scramblase-dependent PS
cell surface exposure as a means to recruit and bind annexin
in the mineralization process. Lastly, the nuclear localization
of PLSCR1 in N1511 cells by day 7 of BMP/Ins treatment
is similar to that observed in fibroblasts and suggests that
PLSCR1 becomes depalmitoylated (67). The precise site of
nuclear interaction is presently under investigation. PS has
been shown both in vivo and in vitro to be required for
annexin binding to the cytoplasmic surface of the chondrocyte to form a Ca2+ channel necessary for mineralization
(6, 35). Interestingly, in those studies the authors concluded
that binding of annexins to the membrane is not sufficient
for channel formation and proposed that a specialized lipid
component is required for annexin II, V, and VI to form
Ca2+ channels. In more recent work, type II collagen has
been shown to interact with annexin V (77). Our results
suggest that the reorganization of the chondrocyte membrane
during the prehypertrophic stage provides a specialized lipid
domain, which is most likely cholesterol- and PS-enriched
membrane rafts. We propose that this reorganization requires
PS externalization, likely in a raft domain, and that this
externalization may provide the driving force for the formation of annexin channels in the membrane. The evidence in
support of this hypothesis seems compelling: chondrocytes
express PLSCR1 on the membrane surface, PS externalization in chondrocytes is shown to be due to a decrease in
APLT activity and an increase in scramblase activity as
chondrocytes undergo hypertrophy, and the activities of these
lipid translocators are directly dependent on membrane
cholesterol content. The role of membrane raft mediated
proteins in mineralization is further supported by the
observation that raft-associated annexin-2 is important in the
osteoblastic mineralization process (78, 79), although those
studies did not analyze cholesterol-dependent lipid translo-
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cators. Further studies in our laboratory designed to understand the molecular mechanism by which altered cholesterol
biosynthesis and lipid redistribution contribute to MV
formation are presently underway.
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